9 results match your criteria: "National Institute of Cardiology in Mexico City[Affiliation]"
J Card Fail
March 2024
Coronary Care Unit, National Institute of Cardiology in Mexico City, Mexico.
PLoS One
August 2022
Coronary Care Unit, National Institute of Cardiology in Mexico City, Mexico City, Mexico.
Glob Heart
February 2022
Coronary Care Unit, National Institute of Cardiology in Mexico City, MX.
Background: Latin America has limited information about the full spectrum cardiogenic shock (CS) and its hospital outcome. This study sought to examine the temporal trends, clinical features and outcomes of patients with CS in a coronary care unit of single Mexican institution.
Methods: This was a retrospective study of consecutive patients hospitalized with CS in a Mexican teaching hospital between 2006-2019.
ESC Heart Fail
February 2021
Coronary Care Unit, National Institute of Cardiology in Mexico City, Juan Badiano, Sección XVI, Tlalpan, Mexico City, 14080, Mexico.
Aims: Little is known regarding acute heart failure (AHF) clinical characteristics and its hospital outcome in Latin America. This study sought to assess the prevalence of, and identify differences among, in-hospital outcomes in patients hospitalized for AHF who were stratified by clinical phenotype at a hospital in Latin America.
Methods And Results: This is a retrospective cohort study of patients with AHF who were hospitalized in the coronary care unit of a Latin American teaching hospital from January 2006 to December 2018.
Am J Emerg Med
January 2021
Coronary Care Unit, National Institute of Cardiology in Mexico City, Mexico.
In the coronavirus disease 2019 (COVID-19) era, the presence of acute respiratory failure is generally associated with acute respiratory distress syndrome; however, it is essential to consider other differential diagnoses that require different, and urgent, therapeutic approaches. Herein we describe a COVID-19 case complicated with bilateral spontaneous pneumothorax. A previously healthy 45-year-old man was admitted to our emergency department with sudden-onset chest pain and progressive shortness of breath 17 days after diagnosis with uncomplicated COVID-19 infection.
View Article and Find Full Text PDFEur Rev Med Pharmacol Sci
July 2020
Coronary Care Unit, National Institute of Cardiology in Mexico City, Mexico City, Mexico.
Although most patients with coronavirus disease 2019 (COVID-19) have a good prognosis, in some cases, the disease progresses rapidly, and the mortality rate is high. Some evidence suggests that infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces a 'cytokine storm', which is related to acute respiratory distress syndrome or multi-organ dysfunction leading to physiological deterioration and death. It is important to highlight the state of hypercoagulability that can be triggered, involving microvascular thrombosis and vascular occlusive events, which are relevant to such poor outcomes.
View Article and Find Full Text PDFAm J Cardiol
April 2017
Department of Immunology, National Institute of Cardiology in Mexico City, Mexico; Department of Health Care, Metropolitan Autonomous University, National Institute of Cardiology in Mexico City, Mexico.
Hypoalbuminemia is a long-term risk factor for incident of both myocardial infarction and heart failure. We assessed whether serum albumin levels at admission are associated with new-onset heart failure and in-hospital mortality in patients with acute coronary syndrome (ACS). The study included 7,192 patients with ACS with no previous history of heart failure.
View Article and Find Full Text PDFTher Clin Risk Manag
October 2014
Coronary Care Unit, National Institute of Cardiology in Mexico City, Mexico City, Mexico.
Background: Among patients with coronary artery disease (CAD), 80%-90% present at least one conventional risk factor. On the other hand, lipid profile modification after a cardiovascular event related to acute coronary syndrome (ACS) has been recognized. The prevalence of conventional risk factors and the lipid profile at the time of admission in patients with ACS and significant CAD (stenosis ≥50%) determined through coronary angiography is not well described.
View Article and Find Full Text PDFInt J Cardiol
March 2014
Coronary Care Unit, National Institute of Cardiology in Mexico City, Mexico.